| Primary |
| Product Used For Unknown Indication |
75.3% |
| Blood Cholesterol Increased |
6.2% |
| Hypercholesterolaemia |
3.8% |
| Hypertension |
2.8% |
| Hyperlipidaemia |
2.0% |
| Prophylaxis |
1.2% |
| Coronary Artery Disease |
0.9% |
| Myocardial Infarction |
0.9% |
| Pain |
0.9% |
| Type 2 Diabetes Mellitus |
0.8% |
| Prostate Cancer |
0.7% |
| Schizophrenia |
0.7% |
| Depression |
0.5% |
| Diabetes Mellitus |
0.5% |
| Hypothyroidism |
0.5% |
| Oedema |
0.5% |
| Cellulitis |
0.4% |
| Dyslipidaemia |
0.4% |
| Myocardial Ischaemia |
0.4% |
| Transient Ischaemic Attack |
0.4% |
|
| Rhabdomyolysis |
17.6% |
| Pain In Extremity |
7.8% |
| Pain |
5.9% |
| Sleep Disorder |
5.9% |
| Amnesia |
4.9% |
| Myalgia |
4.9% |
| Pulmonary Fibrosis |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Nightmare |
3.9% |
| Paraesthesia |
3.9% |
| Renal Failure Acute |
3.9% |
| Swelling Face |
3.9% |
| Systemic Lupus Erythematosus |
3.9% |
| Vertigo |
3.9% |
| Vision Blurred |
3.9% |
| Weight Decreased |
3.9% |
| Cerebrovascular Accident |
2.9% |
| Muscle Spasms |
2.9% |
| Muscular Weakness |
2.9% |
| Rash |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
75.4% |
| Blood Cholesterol Increased |
5.4% |
| Hypercholesterolaemia |
4.3% |
| Myocardial Ischaemia |
3.3% |
| Pain |
1.8% |
| Type Iib Hyperlipidaemia |
1.8% |
| Antiplatelet Therapy |
0.7% |
| Cerebrovascular Accident |
0.7% |
| Contraception |
0.7% |
| Depression |
0.7% |
| Hirsutism |
0.7% |
| Hyperlipidaemia |
0.7% |
| Hypertension |
0.7% |
| Overweight |
0.7% |
| Anxiety |
0.4% |
| Asthma |
0.4% |
| Blood Pressure |
0.4% |
| Cardiac Failure |
0.4% |
| Cholesterosis |
0.4% |
| Coagulation Time Abnormal |
0.4% |
|
| Rhabdomyolysis |
12.0% |
| Dyspnoea |
8.0% |
| Myalgia |
8.0% |
| Weight Increased |
8.0% |
| Alopecia |
4.0% |
| Angioedema |
4.0% |
| Contusion |
4.0% |
| Diabetes Mellitus |
4.0% |
| Emotional Distress |
4.0% |
| Gait Disturbance |
4.0% |
| Haemorrhage Intracranial |
4.0% |
| Hepatotoxicity |
4.0% |
| Malaise |
4.0% |
| Myocardial Infarction |
4.0% |
| Myositis |
4.0% |
| Oedema Peripheral |
4.0% |
| Pancreatitis |
4.0% |
| Paraesthesia |
4.0% |
| Pleurisy |
4.0% |
| Pregnancy On Oral Contraceptive |
4.0% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
20.0% |
| Schizophrenia |
20.0% |
| Epilepsy |
13.3% |
| Abdominal Pain Upper |
6.7% |
| Affective Disorder |
6.7% |
| Antiviral Prophylaxis |
6.7% |
| Arthralgia |
6.7% |
| Back Pain |
6.7% |
| Depression |
6.7% |
| Product Used For Unknown Indication |
6.7% |
|
| White Blood Cell Count Decreased |
25.0% |
| Diarrhoea |
12.5% |
| Hallucination |
12.5% |
| Muscle Spasms |
12.5% |
| Syncope |
12.5% |
| Tracheal Pain |
12.5% |
| Vomiting |
12.5% |
|
| Interacting |
| Product Used For Unknown Indication |
80.0% |
| Metabolic Syndrome |
15.0% |
| Urinary Tract Infection |
5.0% |
|
| Drug Interaction |
33.3% |
| Rhabdomyolysis |
33.3% |
| Stevens-johnson Syndrome |
33.3% |
|
